ST 271
CAS No. 106392-48-7
ST 271( ST-271 | ST271 | ST 271 )
Catalog No. M17133 CAS No. 106392-48-7
ST271 is an effective protein tyrosine kinase (PTK) inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 32 | In Stock |
|
5MG | 50 | In Stock |
|
10MG | 80 | In Stock |
|
25MG | 143 | In Stock |
|
50MG | 245 | In Stock |
|
100MG | 393 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameST 271
-
NoteResearch use only, not for human use.
-
Brief DescriptionST271 is an effective protein tyrosine kinase (PTK) inhibitor.
-
DescriptionST-271 is tyrphostin tyrosine kinase inhibitor. ST271 reduced intracellular Ca2+ levels and inhibited activation of phospholipase C. Elevation of intracellular Ca2+ regulates agonist-induced activation of phospholipase C and that this contributes to the inhibition of thrombin-induced formation of inositol phosphates by the tyrphostin ST271.
-
In VitroST271 partially inhibits peptide phosphorylation in the membrane preparation and in permeabilized platelets. ST271 (100 μM) causes complete inhibition of formation of inositol phosphates induced by FcγRII cross-linking, but also induces a small (< 30%) but significant inhibition of the response to thrombin and U46619.
-
In Vivo——
-
SynonymsST-271 | ST271 | ST 271
-
PathwayOthers
-
TargetOther Targets
-
RecptorPTK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number106392-48-7
-
Formula Weight272.34
-
Molecular FormulaC16H20N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 110 mg/mL 403.91 mM
-
SMILESCC(C)c1cc(cc(c1O)C(C)C)/C=C(\C#N)/C(=O)N
-
Chemical Name(E)-2-Cyano-3-[4-hydroxy-3,5-di(propan-2-yl)phenyl]prop-2-enamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Martinson EA, et al. Inhibition of phospholipase D of human platelets by protein tyrosine kinase inhibitors. Cell Mol Biol (Noisy-le-grand). 1994 Jul;40(5):627-34.
molnova catalog
related products
-
Borofalan(10B)
Borofalan echibits antineoplastic effects. Borofalan can be used in studies on recurrent or locally advanced head and neck cancer.
-
ML213
ML213 is a selective activator of Kv7.2 (KCNQ2) and Kv7.4 (KCNQ4) channels, enhances Kv7.2 and Kv7.4 channels with EC50s of 230 and 510 nM, respectively.
-
TAPI 2
ADAM-17 (TACE) and MMP inhibitor (Ki = 120 nM at ADAM-17). Sensitizes cancer stem cells to the lethal effects of 5-FU in vitro. Blocks shedding of TNF-α from cell membranes.